On 9th February, Pfizer announced Meenakshi Nevatia as the new Additional Director and Managing Director for five years from April 3, 2023.
- Pfizer is a famous drug-making company known development of various vaccines all over the world.
- Earlier the President of Pfizer for India was S. Sridha. But the early announcement of his retirement by him in August 2022, led Pfizer to choose Meenakshi to take his place.
- The US drug-making company’s board, on Thursday, announced, S. Sridha was to be taken down from the position of MD by 31st March 2023.
Meenakshi Nevatia will be the new Indian MD of the company, helping to compete in the Indian market. She has 30 years of experience across various companies including McKinsey & Co., Novartis Pharmaceuticals, and Stryker Corporation.
Continuing the achievement of the journey of effectiveness and credibility of more than 10 years in the career of journalism, as a woman journalist, I am Serving as the founder, promoter and editor of DiaryTimes with the trust and support of all. My credible coverage may not have given a big shape to the numbers, but my journey presents articles that make you aware of the exact and meaningful situations of Himachal’s politics, ground issues related to the public, business, tourism and the difficult geographical conditions of the state and financial awareness. DiaryTimes, full of the experience of my precise editorial expertise, is awakening the flame of credible journalism among all of you, so that the eternal flame of meaningful change can be lit in the life of the people of the state and the atrocities being committed against the people can be brought to the fore, I am motivated for that. If even a small change comes with the power of my journalism and the whole world becomes a witness to that issues, then I will consider myself fortunate.
